Last $1.28 USD
Change Today +0.04 / 3.23%
Volume 705.7K
HNSN On Other Exchanges
As of 8:10 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

hansen medical inc (HNSN) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/11/14 - $2.89
52 Week Low
05/12/14 - $1.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HANSEN MEDICAL INC (HNSN)

Related News

No related news articles were found.

hansen medical inc (HNSN) Related Businessweek News

No Related Businessweek News Found

hansen medical inc (HNSN) Details

Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for the positioning, manipulation, and control of catheters and catheter-based technologies. The company offers Sensei Robotic Catheter Systems and Artisan Control Catheters for the manipulation, positioning, and control of mapping catheters during electrophysiology procedures; and Magellan Robotic System, a peripheral vascular interventional platform, which is used in combination with the Magellan Robotic Catheter for vessel navigation, catheter stability during the manual delivery and placement of therapeutic devices, reduced procedural radiation exposure and fatigue, and precise robotic control of distal catheter tips. The company also provides Lynx catheter, an irrigated ablation catheter; and CoHesion 3D Visualization Module, a software interface, which provides physicians with 3D visualization to augment their ability to move a catheter throughout the atria, as well as increase control over placement of the catheter in specific locations. It sells its products through direct sales force and distributors in the United States, European Union, and internationally. The company has agreements with St. Jude Medical, Inc. to integrate its Sensei system with St. Jude’s Ensite system, as well as to co-market the integrated product; and with Philips Medical Systems Nederland B.V. to co-develop integrated products. Hansen Medical, Inc. was founded in 2002 and is headquartered in Mountain View, California.

171 Employees
Last Reported Date: 03/13/14
Founded in 2002

hansen medical inc (HNSN) Top Compensated Officers

Chief Operating Officer
Total Annual Compensation: $275.0K
Vice President of Marketing & Business Develo...
Total Annual Compensation: $241.5K
Senior Vice President of Global Sales
Total Annual Compensation: $230.0K
Compensation as of Fiscal Year 2013.

hansen medical inc (HNSN) Key Developments

Hansen Medical, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Hansen Medical, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported total revenues of $6,887,000 against $3,343,000 a year ago. Loss from operations was $11,053,000 against $12,499,000 a year ago. Loss before income taxes was $12,275,000 against $13,431,000 a year ago. Net loss was $12,290,000 or $0.11 per basic and diluted share against $13,446,000 or $0.20 per basic and diluted share a year ago. For the six months, the company reported total revenues of $10,586,000 against $6,294,000 a year ago. Loss from operations was $24,231,000 against $28,060,000 a year ago. Loss before income taxes was $26,702,000 against $30,580,000 a year ago. Net loss was $26,735,000 or $0.25 per basic and diluted share against $30,633,000 or $0.45 per basic and diluted share a year ago.

Hansen Medical, Inc. and Adachi Co., Ltd. Announces a Distribution Agreement for Magellan(TM) and Sensei(R) Robotic Systems in Japan

Hansen Medical, Inc. and Adachi Co., Ltd. announced a distribution agreement for Magellan(TM) and Sensei(R) Robotic Systems in Japan. As part of the distribution agreement, Adachi is responsible for obtaining Japanese Marketing approval from the Pharmaceuticals and Medical Devices Agency for the Magellan and Sensei Robotic Systems. Hansen Medical's Intravascular Robotic technologies are designed to deliver accurate robotic catheter control and stability during a wide variety of endovascular and electrophysiology (EP) procedures. Both the Magellan and Sensei Robotic Systems provide for accurate navigation capabilities while allowing the physician to be seated comfortably away from the radiation in a centralized, remote workstation.

Hansen Medical Announces Publication of Uterine Artery Embolization Results

Hansen Medical, Inc. announced that a study, published online in the Journal of Vascular Interventional Radiology, found the use of the Magellan Robotic System in uterine artery embolization, or UAE, procedures is feasible and appears to be safe. Researchers reviewed the results of five patients treated with robot-assisted UAE over a 10 month period at St. Mary's Hospital, Imperial College London. Lead Investigator Dr. Mohammad Hamady and his colleagues conducted the study to investigate the safety and feasibility of the Magellan 9Fr Robotic Catheter in this complex arterial bed. All procedures were successfully completed without local puncture site complications or access vessel injuries. Further, robotic bilateral internal iliac artery cannulation was successfully performed in all cases. At the six-month follow-up mark, all patients reported significant improvement in symptoms and quality-of-life. Uterine fibroids are tumors that grow in a woman's womb. They are the most common benign tumors in women and the leading cause for hysterectomies in the US. As many as 1 in 5 women may have fibroids during their childbearing years. Half of all women have fibroids by age 50. Uterine artery embolization is a minimally-invasive treatment option for uterine fibroids in which a catheter is used to deliver small particles into the uterine artery to stop blood flow to the fibroids.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HNSN:US $1.28 USD +0.04

HNSN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ABIOMED Inc $26.03 USD +0.24
AtriCure Inc $16.11 USD -0.24
LeMaitre Vascular Inc $7.33 USD -0.12
Stereotaxis Inc $3.00 USD 0.00
Spectranetics Corp/The $28.89 USD +0.08
View Industry Companies

Industry Analysis


Industry Average

Valuation HNSN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.5x
Price/Book 17.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANSEN MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at